Quiz: Evolving Treatment Options in BRAF V600E Mutant Metastatic Colorectal Cancer

The FDA cannot approve the application for zolbetuximab in advanced or metastatic gastric or gastroesophageal junction adenocarcinoma due to unresolved issues following a pre-license inspection of a third-party manufacturing site.

In our colorectal cancer quiz, you’ll get to test your knowledge on mismatch-repair deficiency in patients with colorectal cancer and the results of the KEYNOTE-177 trial.

In our gastric cancer quiz, you’ll get to test your knowledge on the prevalence of gastric cancer and what differentiates patients with early-onset gastric cancer.

In our gastrointestinal cancer quiz, you’ll get to test your knowledge on the current treatment options for patients with gastric/gastroesophageal junction cancer, and how the disease impacts patients worldwide.

In our colorectal cancer quiz, you’ll get a chance to test your knowledge on the incidence of colorectal cancer and the risk factors associated with the disease.

In our liver cancer quiz, you’ll get a chance to test your knowledge on recurrence following resection in patients with intrahepatic cholangiocarcinoma and the new tools being developed to aid in treating this patient population.